Drawing for LAKHESYS THE BENCHTOP CELL FACTORY

USPTO serial 79400902

LAKHESYS THE BENCHTOP CELL FACTORY

Reviewed by CopyMark Law Group

Reg. 7877080Status 700Registered
Filing date
Status date
Registration date
Aug 5, 2025
Examiner
CHADAB, SETH WILLIG
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LAKHESYS THE BENCHTOP CELL FACTORY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

H. David Starr

H. David Starr Muncy, Geissler, Olds & Lowe, P.C.125 S. Royal StreetAlexandria, VA 22314United States

Goods and services

ClassDescriptionStatusFirst use
009Scientific apparatus and instruments for analysis, control and detection of biological and cellular material, namely, combination apparatus consisting of microscopes, spectrometers and microfluidic bioprocessors; microfluidic chips; programmable microfluidic chips; downloadable chemical, biological and cellular analysis software for cell manufacturing; downloadable chemical, biological and cellular database software for cell manufacturing; scientific and laboratory apparatus for pharmaceutical production and bioproduction, namely cell culture incubators for scientific use, bioreactors for cell culturing, and cell culturing vessels; bioreactors for laboratories; laboratory and industrial chemical reactors for pharmaceutical productionACTIVE—
010Medical diagnostic apparatus and instruments for biological and cell analyses; medical diagnostic apparatus and instruments for the detection, analysis and handling of genetic material; genomic analysis apparatus for medical use; medical apparatus and instruments for detecting, analyzing and manipulating biological and cell material for medical use.ACTIVE—
042Biological laboratory services; design, development, installation, maintenance and rental of laboratory apparatus and instruments, namely, microfluidic cell production units, microfluidic bioprocessors and microfluidic cartridges; bioproduction services, namely, biochemical development; culturing and manufacturing cells for scientific research purposes; scientific research in the field of biology, and integrated microfluidic bio-production; biological and cell analysis and manipulation services for scientific use; scientific analysis and retrieval of data in the fields of biology and integrated microfluidic bio-production; computer platform as a service (PaaS) featuring software in the field of biology and for cell analysis and manufacturing; design, development, installation, rental and maintenance of computer software in the field of bioproduction and cell production; software as a service (SaaS) featuring software in the field of biology and for cell analysis and manufacturing; information services with respect to scientific research by conducting clinical trialsACTIVE—
044Medical services for biological and cell analysis and manipulation for medical use; medical and health services in biology, namely, provision of health care and medical services by health care professionals; culturing and manufacturing cells for medical therapy purposes, namely, medical treatment of cancer using cultured cells; biological and cell therapy services; medical services for therapy by means of integrated microfluidic bioproduction; information services with respect to biological and cell medical therapiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 5, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 13, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 13, 2026FIMPFINAL DISPOSITION PROCESSED—
Jan 8, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Dec 24, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 24, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Nov 5, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 5, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 5, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 17, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 17, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 11, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 14, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 18, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 18, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 18, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 9, 2024RFNTREFUSAL PROCESSED BY IB—
Oct 24, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 23, 2024RFRRREFUSAL PROCESSED BY MPU—
Oct 18, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 17, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 8, 2024DOCKASSIGNED TO EXAMINER—
Jul 31, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 31, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 25, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance